These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20454815)

  • 1. Molecular modeling studies of Fatty acyl-CoA synthetase (FadD13) from Mycobacterium tuberculosis--a potential target for the development of antitubercular drugs.
    Jatana N; Jangid S; Khare G; Tyagi AK; Latha N
    J Mol Model; 2011 Feb; 17(2):301-13. PubMed ID: 20454815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the role of critical residues and substrate preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis.
    Khare G; Gupta V; Gupta RK; Gupta R; Bhat R; Tyagi AK
    PLoS One; 2009 Dec; 4(12):e8387. PubMed ID: 20027301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mycobacterium tuberculosis very-long-chain fatty acyl-CoA synthetase: structural basis for housing lipid substrates longer than the enzyme.
    Andersson CS; Lundgren CA; Magnúsdóttir A; Ge C; Wieslander A; Martinez Molina D; Högbom M
    Structure; 2012 Jun; 20(6):1062-70. PubMed ID: 22560731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution and Membrane Interaction Dynamics of
    Lundgren CAK; Lerche M; Norling C; Högbom M
    Biochemistry; 2021 May; 60(19):1520-1532. PubMed ID: 33913324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the molecular basis for selective binding of Mycobacterium tuberculosis Asp kinase toward its natural substrates and feedback inhibitors: a docking and molecular dynamics study.
    Chaitanya M; Babajan B; Anuradha CM; Naveen M; Rajasekhar C; Madhusudana P; Kumar CS
    J Mol Model; 2010 Aug; 16(8):1357-67. PubMed ID: 20140471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An acyl-CoA synthetase in Mycobacterium tuberculosis involved in triacylglycerol accumulation during dormancy.
    Daniel J; Sirakova T; Kolattukudy P
    PLoS One; 2014; 9(12):e114877. PubMed ID: 25490545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the interactions of herbal drugs to beta-ketoacyl ACP synthase of Mycobacterium tuberculosis H37Rv.
    Ramesh KV; Purohit M; Mekhala K; Krishnan M; Wagle K; Deshmukh S
    J Biomol Struct Dyn; 2008 Apr; 25(5):481-93. PubMed ID: 18282003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor binding studies of
    Mallavarapu BD; Abdullah M; Saxena S; Guruprasad L
    J Biomol Struct Dyn; 2019 Sep; 37(14):3751-3763. PubMed ID: 30239262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis.
    Tripathi A; Wadia N; Bindal D; Jana T
    Indian J Biochem Biophys; 2012 Dec; 49(6):435-41. PubMed ID: 23350278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
    Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
    J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.
    Baran M; Grimes KD; Sibbald PA; Fu P; Boshoff HIM; Wilson DJ; Aldrich CC
    Eur J Med Chem; 2020 Sep; 201():112408. PubMed ID: 32574901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based inhibitor design of AccD5, an essential acyl-CoA carboxylase carboxyltransferase domain of Mycobacterium tuberculosis.
    Lin TW; Melgar MM; Kurth D; Swamidass SJ; Purdon J; Tseng T; Gago G; Baldi P; Gramajo H; Tsai SC
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3072-7. PubMed ID: 16492739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based in-silico rational design of a selective peptide inhibitor for thymidine monophosphate kinase of mycobacterium tuberculosis.
    Kumar M; Sharma S; Srinivasan A; Singh TP; Kaur P
    J Mol Model; 2011 May; 17(5):1173-82. PubMed ID: 20697760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resisting resistant Mycobacterium tuberculosis naturally: mechanistic insights into the inhibition of the parasite's sole signal peptidase Leader peptidase B.
    Dhiman H; Dhanjal JK; Sharma S; Chacko S; Grover S; Grover A
    Biochem Biophys Res Commun; 2013 Apr; 433(4):552-7. PubMed ID: 23510997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
    Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
    FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations.
    Sengupta S; Roy D; Bandyopadhyay S
    J Biomol Struct Dyn; 2015; 33(12):2655-66. PubMed ID: 25669125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward the virtual screening of potential drugs in the homology modeled NAD+ dependent DNA ligase from Mycobacterium tuberculosis.
    Singh V; Somvanshi P
    Protein Pept Lett; 2010 Feb; 17(2):269-76. PubMed ID: 20214650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies.
    Maganti L; Open Source Drug Discovery Consortium ; Ghoshal N
    J Biomol Struct Dyn; 2014; 32(2):273-88. PubMed ID: 23527569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.